The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Survival of metastatic breast carcinoma patients over a 20‐year period: A retrospective analysis based on individual patient data from six consecutive studies
Open accessAbstract
BACKGROUND: The expectation of improvement in patient survival with administration of new chemotherapy agents for metastatic breast carcinoma (MBC) is not consistently supported by data from clinical trials, which are often underpowered and have not detected moderate survival advantage. The aim of this study was to evaluate the impact of new agents on prognosis of MBC patients enrolled in clinical trials of first‐line chemotherapy. METHODS: Between 1983 and 2001, 640 MBC patients were entered into 6 consecutive trials; the present analysis was limited to patients. The date of diagnosis of metastatic breast disease was used to define 5 arbitrarily chosen 3‐year time cohorts, 1983–1986, 1987–1989, 1992–1994, 1995–1997, and 1998–2001. Multivariate proportion of hazard (PH) models were used to evaluate changes in overall survival (OS) and progression‐free survival (PFS) over time and to detect changes associated with the use of taxanes, while adjusting for differences in baseline factors among 5 cohorts. RESULTS: Patient characteristics were evenly distributed across the 5 cohorts. Median OS was 18 months, 17.2 months, 19.2 months, 26.1 months, and 23.6 months, respectively, in cohorts 1983–1986, 1987–1989, 1992–1994, 1995–1997, 1998–2001 (P < 0.0001). Age, performance status, relapse‐free survival, type of adjuvant treatment, metastatic site, and taxane first‐line chemotherapy were all associated with survival. These data failed to provide an indication of temporal trend and suggested a reduction in hazard of death in two cohorts (1995–1997 and 1998–2001) where taxane was added to first‐line chemotherapy. CONCLUSIONS: The analysis provided evidence of improvement in prognosis of MBC patients that was associated with use of modern chemotherapeutic agents independent of time. Cancer 2005. © 2005 American Cancer Society.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Reporting results of cancer treatment
Miller, A. B., Hoogstraten, B., Staquet, M., & Winkler, A. (1981) · Cancer · doi:10.1002/1097-0142(19810101)47:1<207::aid-cncr2820470134>3.0.co;2-6 · Cited by 7,793
The Regression Analysis of Binary Sequences
Cox, D. R. (1958) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1958.tb00292.x · Cited by 2,813
Fossati, R., Confalonieri, C., Torri, V, Ghislandi, E., Penna, A., Pistotti, V, Tinazzi, A., & Liberati, A. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.10.3439 · Cited by 546
Giordano, S. H., Buzdar, A. U., Smith, T. L., Kau, S., Yang, Y., & Hortobagyi, G. N. (2004) · Cancer · doi:10.1002/cncr.11859 · Cited by 540
Breast Cancer With Synchronous Metastases: Trends in Survival During a 14-Year Period
Andre, F., Slimane, K., Bachelot, T., Dunant, A., Namer, M., Barrelier, A., Kabbaj, O., Spano, J. P., Marsiglia, H., Rouzier, R., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.095 · Cited by 394
The Regression Analysis of Binary Sequences
Cox, D. R. (1959) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1959.tb00334.x · Cited by 321
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
Stockler, M., Wilcken, N. R. C., Ghersi, D., & Simes, R. J. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0161 · Cited by 218
Taxane-containing regimens for metastatic breast cancer
Ghersi, D., Willson, M. L., Chan, M. M. K., Simes, J., Donoghue, E., & Wilcken, N. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003366.pub3 · Cited by 189
Venturini, M., Michelotti, A., Del Mastro, L., Gallo, L., Carnino, F., Garrone, O., Tibaldi, C., Molea, N., Bellina, R. C., Pronzato, P., et al. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.12.3112 · Cited by 165
Self-citationCardoso, F., Leo, A. D., Lohrisch, C. A., Bernard, C., Ferreira, F., & Piccart, M. J. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf101 · Cited by 146
Rahman, Z. U., Frye, D. K., Smith, T. L., Asmar, L., Theriault, R. L., Buzdar, A. U., & Hortobágyi, G. N. (1999) · Cancer · Cited by 133
Conte, P., Baldini, E., Gennari, A., Michelotti, A., Salvadori, B., Tibaldi, C., Danesi, R., Innocenti, F., Gentile, A., Dell'Anna, R., et al. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.7.2510 · Cited by 90
Self-citationLeo, A. D., Bleiberg, H., & Buyse, M. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.99.089 · Cited by 79
Conte, P., Guarneri, V., Bruzzi, P., Prochilo, T., Salvadori, B., Bolognesi, A., Aldrighetti, D., Venturini, M., Rosso, R., Mammoliti, S., et al. (2004) · Cancer · doi:10.1002/cncr.20400 · Cited by 70
Self-citationTaxane containing regimens for metastatic breast cancer
Ghersi, D., Wilcken, N. R. C., Simes, J. R., & Donoghue, E. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003366.pub2 · Cited by 64
Conte, P., Pronzato, P., RUBAGOTTI, A., Alama, A., Amadori, D., Demicheli, R., Gardin, G., Gentilini, P., Jacomuzzi, A., & Lionetto, R. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.3.339 · Cited by 62
Self-citationUse and abuse of taxanes in the management of metastatic breast cancer
Bernard-Marty, C., Cardoso, F., & Piccart, M. J. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00538-0 · Cited by 24
Cited by
Brain Metastases: The HER2 Paradigm
Lin, N. U., & Winer, E. P. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2478 · Cited by 417
Caswell-Jin, J. L., Plevritis, S. K., Tian, L., Cadham, C. J., Xu, C., Stout, N. K., Sledge, G. W., Mandelblatt, J. S., & Kurian, A. W. (2018) · JNCI Cancer Spectrum · doi:10.1093/jncics/pky062 · Cited by 315
Breast cancer lung metastasis: Molecular biology and therapeutic implications
Jin, L., Han, B., Siegel, E., Cui, Y., Giuliano, A., & Cui, X. (2018) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1456599 · Cited by 295
Thomas, E., Tabernero, J., Fornier, M., Conté, P., Fumoleau, P., Lluch, A., Vahdat, L. T., Bunnell, C. A., Burris, H. A., Viens, P., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9102 · Cited by 290
The antitumour effects of caloric restriction are mediated by the gut microbiome
Mao, Y.-Q., Huang, J.-T., Zhang, S.-L., Kong, C., Li, Z.-M., Jing, H., Chen, H.-L., Kong, C.-Y., Huang, S.-H., Cai, P.-R., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-022-00716-4 · Cited by 84
Metadata
- Authors
- Gennari, A., Conte, P., Rosso, R., Orlandini, C., & Bruzzi, P.
- Venue
- Cancer
- Publisher
- Wiley
- Published
- 2005-10-03
- Volume
- 104
- Issue
- 8
- Pages
- 1742-1750
- ISSN
- 0008-543X (ISSN-L)
- 1097-0142
- OpenAlex
- W1596105818
- Cited by
- 280
- References
- 18
- FWCI
- 4.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.